Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

174.27 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,614
Open 174.27
Bid (Size) 173.25 (1)
Ask (Size) 174.50 (1)
Prev. Close 174.27
Today's Range 174.27 - 174.27
52wk Range 115.61 - 497.49
Shares Outstanding 392,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
2022 Returns For Investor And Pandemic Darlings: You Won't Believe This Stock That Is Positive On The Year
2022 has been an uncertain year in the markets, to say the least. A number of second-quarter big tech earnings were delivered in recent weeks, showing signs of stability in the macro environment and... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga

Performance

YTD
-25.86%
-25.86%
1 Month
-0.56%
-0.56%
3 Month
+41.19%
+41.19%
6 Month
+6.24%
+6.24%
1 Year
-61.85%
-61.85%

More News

Read More
Why Is Novavax (NVAX) Stock Plunging 30%?
Via InvestorPlace
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
Moderna Whale Trades Spotted
Via Benzinga
Why Moderna Shares Are Falling Following BioNTech's Earnings Results
Via Benzinga
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
Via Benzinga
Two Appealing Biotech Stocks for Two Distinct investors
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Looking Into Moderna's Recent Short Interest
Via Benzinga
Moderna And the European Commission (EC) Amend Covid-19 Vaccine Agreement to Supply Omicron-Containing Bivalent Candidates; EC Purchases Additional 15 million Doses
Via ACCESSWIRE
Small Cap Biotechs Perk Up On Dealmaking
Via Talk Markets
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
Via Investor's Business Daily
Looking At Moderna's Recent Whale Trades
Via Benzinga
Baillie Gifford Just Doubled Down on Affirm (AFRM) Stock
Via InvestorPlace
Moderna To $74? Here Are 5 Other Price Target Changes For Thursday
Via Benzinga
Oil Falls Amid Rise In Reserves, China Is Creating A Blockade On Taiwan
Via Talk Markets
How Siga Is Turning Its Biowarfare Soldier Onto This Outbreak ... And The Next
Via Investor's Business Daily
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Market Volatility Declines Sharply After Nasdaq Jumps More Than 300 Points
Via Benzinga
Moderna, PayPal And Some Other Big Gainers From Wednesday
Via Benzinga
Nasdaq Surges Over 300 Points; Moderna Earnings Beat Expectations
Via Benzinga
Here's Why Novavax Shares Are Moving
Via Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Here's Why BioNTech Stock Is Moving
Via Benzinga
New Tensions Between The US And China Provoked Investors To Return To Safe-Haven Assets
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.